Zobrazeno 1 - 10
of 189
pro vyhledávání: '"Jesus San‐Miguel"'
Autor:
Enrique M. Ocio, Aurore Perrot, Philippe Moreau, Maria‐Victoria Mateos, Sara Bringhen, Joaquín Martínez‐López, Lionel Karlin, Song‐Yau Wang, Corina Oprea, Yi Li, Ercem Kodas, Jesus San‐Miguel
Publikováno v:
HemaSphere, Vol 8, Iss 11, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/6f512f0c1c04412f938e07f19b14f6ba
Autor:
Francesca Di Giuseppe, Claudia Vitolo, Christopher Barnard, Giorgio Libertá, Pedro Maciel, Jesus San-Miguel-Ayanz, Sebastien Villaume, Fredrik Wetterhall
Publikováno v:
Scientific Data, Vol 11, Iss 1, Pp 1-10 (2024)
Abstract The European Centre for Medium range weather forecast (ECMWF) on behalf of the Copernicus Emergency Management Service (CEMS) has recently widened the fire danger data offering in the Climate Data Store (CDS) to include a set of fire danger
Externí odkaz:
https://doaj.org/article/8375430e28cb4b73b2638d248ebffc13
Autor:
Enrique M. Ocio, Sara Bringhen, Joaquin Martinez-Lopez, Jesus San-Miguel, Stefania Oliva, Paula Rodriguez-Otero, Nadia Le Roux, Yvonne Dong, Severine Doroumian, Sandrine Macé, Maria-Victoria Mateos
Publikováno v:
HemaSphere, Vol 7, Iss 2, p e829 (2023)
Externí odkaz:
https://doaj.org/article/4f2b10bc60bc4c0fa2b3b7b2010e704c
Autor:
Stefan Knop, Maria-Victoria Mateos, Meletios A. Dimopoulos, Kenshi Suzuki, Andrzej Jakubowiak, Chantal Doyen, Paulo Lucio, Zsolt Nagy, Ganna Usenko, Ludek Pour, Mark Cook, Sebastian Grosicki, Andre Crepaldi, Anna Marina Liberati, Philip Campbell, Tatiana Shelekhova, Sung-Soo Yoon, Genadi Losava, Tomoaki Fujisaki, Mamta Garg, Jianping Wang, Susan Wroblewski, Anupa Kudva, Katharine S. Gries, John Fastenau, Jesus San-Miguel, Michele Cavo
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background In the phase III ALCYONE trial, daratumumab plus bortezomib/melphalan/prednisone (D-VMP) significantly improved overall response rate and progression-free status compared with VMP alone in transplant-ineligible patients with newly
Externí odkaz:
https://doaj.org/article/b999c61f13244d59a68cdf925de95954
Autor:
Emilio Chuvieco, Marta Yebra, Simone Martino, Kirsten Thonicke, Marta Gómez-Giménez, Jesus San-Miguel, Duarte Oom, Ramona Velea, Florent Mouillot, Juan R. Molina, Ana I. Miranda, Diogo Lopes, Michele Salis, Marin Bugaric, Mikhail Sofiev, Evgeny Kadantsev, Ioannis Z. Gitas, Dimitris Stavrakoudis, George Eftychidis, Avi Bar-Massada, Alex Neidermeier, Valerio Pampanoni, M. Lucrecia Pettinari, Fatima Arrogante-Funes, Clara Ochoa, Bruno Moreira, Domingos Viegas
Publikováno v:
Fire, Vol 6, Iss 5, p 215 (2023)
This paper presents a review of concepts related to wildfire risk assessment, including the determination of fire ignition and propagation (fire danger), the extent to which fire may spatially overlap with valued assets (exposure), and the potential
Externí odkaz:
https://doaj.org/article/234a5e7a12f6420dad38473dafa60246
Autor:
Giovanni Palladini, Bruno Paiva, Ashutosh Wechalekar, Margherita Massa, Paolo Milani, Marta Lasa, Sriram Ravichandran, Isabel Krsnik, Marco Basset, Leire Burgos, Mario Nuvolone, Ramón Lecumberri, Andrea Foli, Noemi Puig, Melania Antonietta Sesta, Margherita Bozzola, Pasquale Cascino, Alice Nevone, Jessica Ripepi, Pierpaolo Berti, Simona Casarini, Ombretta Annibali, Alberto Orfao, Jesus San-Miguel, Giampaolo Merlini
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 2, Pp 1-7 (2021)
Abstract Light chain (AL) amyloidosis is caused by a small B-cell clone producing light chains that form amyloid deposits and cause organ dysfunction. Chemotherapy aims at suppressing the production of the toxic light chain (LC) and restore organ fun
Externí odkaz:
https://doaj.org/article/1af0c29e396946d49b7a958dc256ed9f
Autor:
Jesus San-Miguel
Publikováno v:
HemaSphere, Vol 6, Pp 3-4 (2022)
Externí odkaz:
https://doaj.org/article/7d79010e0a08493b80d2ff6b15ad1282
Autor:
Jesus San-Miguel, Saad Z. Usmani, Maria-Victoria Mateos, Niels W.C.J. van de Donk, Jonathan L. Kaufman, Philippe Moreau, Albert Oriol, Torben Plesner, Lotfi Benboubker, Kevin Liu, Peter Hellemans, Tara Masterson, Pamela L. Clemens, Man Luo, Andrew Farnsworth, Hareth Nahi, Ajai Chari
Publikováno v:
Haematologica, Vol 106, Iss 6 (2020)
Intravenous daratumumab is approved for the treatment of multiple myeloma. In Part 1 of the PAVO study, a mix-and-deliver subcutaneous formulation of daratumumab with recombinant human hyaluronidase PH20 (rHuPH20) was well tolerated, with low rates o
Externí odkaz:
https://doaj.org/article/e2c1d565f304411f99b9a9f544f1c8fa
Autor:
Meletios A. Dimopoulos, Jesus San-Miguel, Andrew Belch, Darrell White, Lotfi Benboubker, Gordon Cook, Merav Leiba, James Morton, P. Joy Ho, Kihyun Kim, Naoki Takezako, Philippe Moreau, Jonathan L. Kaufman, Heather J. Sutherland, Marc Lalancette, Hila Magen, Shinsuke Iida, Jin Seok Kim, H. Miles Prince, Tara Cochrane, Albert Oriol, Nizar J. Bahlis, Ajai Chari, Lisa O’Rourke, Kaida Wu, Jordan M. Schecter, Tineke Casneuf, Christopher Chiu, David Soong, A. Kate Sasser, Nushmia Z. Khokhar, Hervé Avet-Loiseau, Saad Z. Usmani
Publikováno v:
Haematologica, Vol 103, Iss 12 (2018)
In the POLLUX study, daratumumab plus lenalidomide/dexamethasone significantly reduced risk of progression/death versus lenalidomide/dexamethasone alone in relapsed/refractory multiple myeloma. We provide one additional year of follow up and include
Externí odkaz:
https://doaj.org/article/34bc86c721f547c0b175882c23aa9838
Autor:
Nicolas Martinez-Calle, Paula Rodriguez-Otero, Sara Villar, Luis Mejías, Ignacio Melero, Felipe Prosper, Patricia Marinello, Bruno Paiva, Miguel Idoate, Jesus San-Miguel
Publikováno v:
Haematologica, Vol 103, Iss 7 (2018)
Externí odkaz:
https://doaj.org/article/f191e6cdf0d04b56b39232786fd2e163